Molecular profiling of liquid biopsies from patients (pts) with bone metastatic castration-resistant prostate cancer (BM-CRPC) treated with radium-223 (RA-223) to reveal differential enrichment for markers that correlate with overall survival (OS).-MedSci.cn

Molecular profiling of liquid biopsies from patients (pts) with bone metastatic castration-resistant prostate cancer (BM-CRPC) treated with radium-223 (RA-223) to reveal differential enrichment for markers that correlate with overall survival (OS).

Corn, PG; Subudhi, SK; Araujo, JC; Vardaki, I; Aparicio, A; Tu, SM; Pagliaro, LC; Zurita, AJ; Logothetis, C; Panaretakis, T

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (6):

科室
- - 订阅+
  - 更多科室
工具
服务